A vibrant and diverse continent, home to over 650 million people and the highest life expectancy among developing regions, Latin America is now…

In a wide-ranging interview, AbbVie’s Flavio Devoto outlines some of the key access challenges and opportunities in the diverse Latin American…

In light of ongoing geopolitical tension, a globally unfavourable macroeconomic environment and new drug-pricing legislation in the US, at the recent…

Latin America is renowned for its creative geniuses – think footballers like Lionel Messi and Pelé; magical realist authors such as Gabriel García…

Some of the most important stories emanating from the Central and Eastern European (CEE) region’s pharma industry, including Polpharma's bid for…

A roundup of the latest UK healthcare, pharma and biotech news including AbbVie and Lilly's departure from the country's voluntary medicines pricing…

Three country managers with a recent experience of bringing new products from their company's global portfolio into Egypt – and with big plans for…

After Big Pharma lobby groups suffered a major drug pricing blow earlier this year with the passage of the US Inflation Reduction Act (IRA), pharma…

AbbVie’s GM for Egypt & Levant, Ali Sleiman, explains the factors behind the stellar growth that has made the cluster one of the company’s…

China’s strict ‘dynamic COVID-zero’ policy, relying on lockdowns, mass-testing and border controls to stamp out COVID-19 outbreaks wherever they…

With the brief tenure of Liz Truss as Prime Minister already drawing to a close, the UK faces yet another new leader as the country attempts to…

Recent announcements from Ipsen and AbbVie of multimillion Euro investments into Irish manufacturing plants underline the Celtic nation’s continuing…